本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Revolution Medicines, Inc.

204.86
-0.2500-0.12%
盤後204.50-0.3600-0.18%19:34 EDT
成交量:126.88萬
成交額:2.58億
市值:439.09億
市盈率:-22.96
高:207.00
開:206.98
低:200.24
收:205.11
52周最高:224.31
52周最低:42.18
股本:2.14億
流通股本:1.85億
量比:0.90
換手率:0.69%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
淨資產收益率:-79.09%
總資產收益率:-30.12%
市淨率:16.85
市盈率(LYR):-34.43

資料載入中...

2026/04/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/15

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/04/13

重要事件披露

Form 8-K - Current report
2026/03/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities